JENNIFER MELISSA MARTINEZ
Physician Assistants & Advanced Practice Nursing Providers|Nurse Practitioner|Family TAMPA, FL NPI 1306605407
Browse related groups: Physician Assistants & Advanced Practice Nursing Providers|Nurse Practitioner|Family FL Merck Sharp & Dohme Corporation All categories
General Payments — all program years on this page
$664.54
- Category: General Payments
- Program years: PY2024
- Record count: 30
- As of (CMS publication): 2026-01-23
Latest program year (PY2024): $664.54 across 30 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2024) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $664.54 | 30 |
By paying entity
Latest program year (PY2024) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| Merck Sharp & Dohme Corporation | $95.68 | 4 |
| Genentech USA, Inc. | $55.08 | 2 |
| Lilly USA, LLC | $49.33 | 2 |
| EISAI INC. | $47.16 | 2 |
| Alexion Pharmaceuticals, Inc. | $46.93 | 2 |
| Gilead Sciences, Inc. | $44.24 | 2 |
| Legend Biotech USA Inc. | $35.09 | 2 |
| Rigel Pharmaceuticals, Inc. | $33.67 | 1 |
| JAZZ PHARMACEUTICALS INC. | $30.90 | 2 |
| GENZYME CORPORATION | $27.43 | 1 |
| BeiGene USA, Inc. | $25.19 | 1 |
| SERVIER PHARMACEUTICALS LLC | $22.53 | 1 |
| Karyopharm Therapeutics Inc. | $22.44 | 1 |
| Genmab U.S., Inc. | $20.81 | 1 |
| PUMA BIOTECHNOLOGY, INC. | $20.15 | 1 |
| Sumitomo Pharma America, Inc. | $19.68 | 1 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $19.31 | 1 |
| Regeneron Healthcare Solutions, Inc. | $18.80 | 1 |
| Pharmacosmos Therapeutics Inc. | $15.77 | 1 |
| PFIZER INC. | $14.35 | 1 |
By program year
| Program year | Amount | Records |
|---|---|---|
| 2024 | $664.54 | 30 |
Records — PY2024 (30)
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.